XOLAIR Trademark

Trademark Overview

On Friday, September 5, 2003, a trademark application was filed for XOLAIR with the United States Patent and Trademark Office. The USPTO has given the XOLAIR trademark a serial number of 78296612. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, March 30, 2016. This trademark is owned by NOVARTIS AG. The XOLAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of IgE-mediated disorders
xolair

General Information

Serial Number78296612
Word MarkXOLAIR
Filing DateFriday, September 5, 2003
Status800 - REGISTERED AND RENEWED
Status DateWednesday, March 30, 2016
Registration Number3086141
Registration DateTuesday, April 25, 2006
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of IgE-mediated disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2003
Primary Code005
First Use Anywhere DateWednesday, December 31, 2003
First Use In Commerce DateWednesday, December 31, 2003

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Saturday, December 4, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 8, 2004ASSIGNED TO EXAMINER
Monday, March 8, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2004NOTICE OF PUBLICATION
Tuesday, May 11, 2004PUBLISHED FOR OPPOSITION
Tuesday, August 3, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 18, 2004PAPER RECEIVED
Wednesday, March 1, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 28, 2005SOU TEAS EXTENSION RECEIVED
Friday, January 28, 2005SOU EXTENSION 1 FILED
Monday, February 14, 2005SOU EXTENSION 1 GRANTED
Tuesday, August 2, 2005SOU TEAS EXTENSION RECEIVED
Tuesday, August 2, 2005SOU EXTENSION 2 FILED
Tuesday, August 2, 2005SOU EXTENSION 2 GRANTED
Thursday, February 2, 2006TEAS STATEMENT OF USE RECEIVED
Thursday, February 2, 2006USE AMENDMENT FILED
Tuesday, February 28, 2006STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 8, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, April 25, 2006REGISTERED-PRINCIPAL REGISTER
Friday, September 9, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, April 25, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 3, 2006ASSIGNED TO LIE
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2011TEAS SECTION 8 & 15 RECEIVED
Friday, September 9, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 9, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 25, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 7, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 30, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 21, 2016TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 30, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 30, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 30, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

xolair disorders mediated treatment preparations pharmaceutical